Ferndale Healthcare

What Ferndale Healthcare does

Ferndale Healthcare, Inc. is a privately held, Detroit, Michigan-headquartered over-the-counter (OTC) pharmaceutical company that traces its origins to the J.F. Hartz Company founded in 1897, was rebranded as Ferndale Laboratories, Inc. in the 1950s, and was re-incorporated in 2010 as a specialty-focused subsidiary of Ferndale Pharma Group, Inc. The company operates from a 51-100 employee base and focuses exclusively on two narrow therapeutic segments: dermatologic conditions (bruising, dry skin, itch, photo damage, purpura, hyperkeratosis) and benign anorectal disorders (hemorrhoids, pruritus ani, perianal discomfort).

Its commercial portfolio is intentionally narrow, comprising four registered-trademark products: LMX4, a 4% lidocaine topical anesthetic for minor pain and itch; LMX5, a 5% lidocaine formulation (the maximum strength available without a prescription) targeted at anorectal pain; Prax Lotion, a non-steroidal anti-itch lotion for the perianal area; and OC8 Professional Mattifying Gel, a consumer-skincare product differentiated by the proprietary ACRYSORB micro-particle technology, which delivers clinically demonstrated 8-hour oil absorption and shine control. The differentiators cited — ACRYSORB in OC8 and maximum-OTC-strength lidocaine in LMX4/LMX5 — are formulation- and materials-science advantages, not platform or data advantages; clinical efficacy is documented in studies published in the Cosmetic Dermatology journal.

Commercially, Ferndale Healthcare generates revenue through one-time consumer purchases of OTC units sold via U.S. retail and pharmacy channels, supplemented by an explicit healthcare-professional referral pathway in which dermatologists, colon-rectal surgeons, and gastroenterologists recommend the products to patients. The go-to-market motion is direct-to-consumer/OTC, reinforced by a 100% 30-day money-back guarantee on OC8, LMX4, and LMX5, celebrity and professional endorsements (notably Dr. Jessica Wu and makeup departments of American Idol and The Glee Project for OC8), peer-reviewed clinical evidence citations, and linked referrals to the American Academy of Dermatology, American Society of Colon and Rectal Surgeons, American College of Gastroenterology, and American Contact Dermatitis Society. No revenue figures, funding events, M&A activity, or geographic expansions beyond the United States are disclosed in the source material, and there is no indicated AI/ML, app, or API surface to the business.

Name

Ferndale Healthcare

Legal name

Ferndale Healthcare Distribution

Website

https://ferndalehealthcare.com

Company type

Private

Founded year

1897

Operating status

Operating

Headcount range

51–100 employees

Short description

Ferndale Healthcare, founded in 1897 and based in Detroit, is a private OTC pharmaceutical subsidiary of Ferndale Pharma Group. It sells LMX4, LMX5, OC8 Mattifying Gel, and Prax Lotion through retail, pharmacy, and healthcare professional channels to treat dermatologic and anorectal conditions.

Ownership category

akta.pro rank

Product category

Over-the-Counter Pharmaceuticals

NAICS

Surface Active Agent Manufacturing (325613)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Dermatology & Topical Skin Treatments (HLAIADAE)

akta.pro secondary industries

OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC), Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF)

Keywords

• Over-the-counter pharmaceuticals
• Topical anesthetics
• Lidocaine formulations
• Dermatological OTC products
• Anorectal treatments

Headquarters

HQ city

Detroit

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Over-the-Counter Pharmaceutical Product Sales: Ferndale Healthcare generates revenue through the sale of over-the-counter (OTC) healthcare products including LMX4, LMX5, OC8 Professional Mattifying Gel, and Prax Lotion. These are one-time purchase consumer healthcare products sold through retail and direct channels.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Ferndale Healthcare manufactures and sells a focused portfolio of over-the-counter (OTC) healthcare products including topical lidocaine-based anesthetics (LMX4 4% lidocaine and LMX5 5% lidocaine), an ACRYSORB-based mattifying gel (OC8), and a non-steroidal anti-itch lotion (Prax). The products target dermatologic conditions and benign anorectal disorders and are sold without a prescription through retail, pharmacy, and direct channels.

Product overview

Ferndale Healthcare offers a focused portfolio of four over-the-counter healthcare products: LMX4 (4% Lidocaine) and LMX5 (5% Lidocaine) are topical anesthetics providing temporary pain and itch relief for minor skin conditions and anorectal disorders; OC8 Professional Mattifying Gel is a skincare product with ACRYSORB technology for 8-hour shine control; and Prax Lotion is a non-steroidal anti-itch treatment for the perianal area. The company targets dermatologic conditions and benign anorectal disorders with products available without prescription.

Differentiator

Problem solved

Functional benefit

Products and services

• LMX4 Topical anesthetic containing 4% Lidocaine for temporary relief of pain and itching due to minor cuts, sunburn, scrapes, skin irritations, burns, and insect bites. Sold over the counter.
• LMX5 Topical anesthetic containing 5% Lidocaine (maximum strength available without a prescription) for fast, effective temporary pain relief, primarily indicated for anorectal disorders.
• OC8 Professional Mattifying Gel Mattifying gel with ACRYSORB micro-particle technology providing an 8-hour formula that traps facial oils to reduce shine and redness; clinically proven to improve the appearance of facial foundation. Used by professional makeup artists and dermatologists.
• Prax Lotion Non-steroidal lotion providing fast relief from itch and discomfort in the perianal area; intended for temporary relief of discomfort and itch.

Quantifiable outcome

• OC8 provides 8-hour shine control with clinically proven reduction in facial oiliness and improved appearance of facial foundation
• +1 more outcomes

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Ferndale Pharma Group, Inc.coreOthersFerndale Healthcare Inc. was incorporated in 2010 as part of the Ferndale Pharma Group, Inc. The company is a proud member of the Ferndale Pharma Group, which encompasses the healthcare business unit. The parent company traces its roots to 1897 when it was founded as the J.F. Hartz Company in Detroit, Michigan.

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Direct peers

• Bausch Health: Diversified dermatology and consumer health company with OTC dermatology brands such as Dermarest; competes with Ferndale's dermatology and anorectal specialty franchises.
• Chattem (Sanofi Consumer Healthcare): US OTC specialty brand portfolio under Sanofi that includes Gold Bond and Aspercreme — directly comparable to Ferndale's LMX/Prax topical pain and skin-conditioning franchises in retail pharmacy channels.
• Bayer Consumer Health: Major OTC marketer of topical lidocaine/pain relief products (e.g., Aspercreme), competing head-to-head with LMX4 and LMX5 across US retail and pharmacy.
• Prestige Consumer Healthcare: Specialty OTC roll-up whose dermatology and topical brands (e.g., Compound W, Dermarest) compete in adjacent specialty OTC categories with similar size, scale and channel mix as Ferndale.
• Church & Dwight: Diversified OTC consumer health company with multiple specialty skincare and OTC brands; comparable go-to-market through mass and drug channels and competes with Ferndale's dermatology and topical franchises.
• Moberg Pharma: Small specialty OTC dermatology company (e.g., Kerasal nail treatment) — directly comparable as a niche, dermatology-focused OTC brand of similar size and channel profile.

Broad incumbents

• Haleon: Global OTC leader (Voltaren, Advil, Centrum) with topical pain and skincare franchises that compete against LMX and Prax in retail pharmacy, though at materially larger scale.
• Johnson & Johnson Consumer Health: Largest OTC consumer health player with topical OTC brands such as Bengay and Neosporin — overlaps with Ferndale's LMX lidocaine franchise but operates at much broader scale and portfolio breadth.
• Galderma: Dermatology-focused company with OTC-adjacent brands such as Cetaphil and Differin OTC; overlaps with Ferndale's dermatology specialty positioning but with broader prescription and OTC reach.

Emerging players

• Crown Therapeutics (Derma Sciences): Specialty dermatology and wound-care OTC company of comparable scale to Ferndale, with overlapping HCP recommendation channels in dermatology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ferndale-healthcare-inc.

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ferndale Healthcare